# Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

> **NCT03631004** · PHASE2,PHASE3 · COMPLETED · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 100 (actual)

## Conditions studied

- Postoperative Nausea
- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT03631004
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2021-02-10
- **Final completion:** 2021-02-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03631004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03631004, "Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03631004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*